论文部分内容阅读
Evonik achieved significant performance inthe Greater China Region, with sales of Euro592 million, up 5% year-on-year.The regional “Growth Path” initiativelaunched in the fall of 2008 - a strategicdevelopment plan in the medium term - hasachieved impressive results, with a numberof investments are being under progress.InNanning of Guangxi region Evonik startedup a new production facility for pharmaceuticalactive ingredients.At the facility in
Evonik achieved significant performance in Greater China Region, with sales of Euro592 million, up 5% year-on-year. The regional “Growth Path” initiativelaunched in the fall of 2008 - a strategic development plan in the medium term - hasachieved impressive results , with a number of investments are being under progress. Naning of Guangxi region Evonik started up a new production facility for pharmaceutically active ingredients. At the facility in